- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04976751
Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China
July 14, 2021 updated by: Yuan Jianlin-1, Xijing Hospital
To carry out real world research on the application of electrophysiology and other suitable technologies in the prevention and treatment of male diseases in medical institutions at all levels in Northwest China, and establish a database for the prevention and treatment of male diseases in Northwest China, so as to provide a basis for the formulation of guidelines or consensus on the application of electrophysiology for the prevention and treatment of male diseases in China.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
274
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yuan Jianlin, doctor
- Phone Number: 86-029-84775321
- Email: jianliny@fmmu.edu.cn
Study Contact Backup
- Name: Lu Jun, master
- Phone Number: 86-029-84775321
- Email: lujun901101@sina.com
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710032
- Recruiting
- Xijing Hospital, Fourth Military Medical University
-
Contact:
- Fei Wu, master
- Phone Number: +86-029-84771794
- Email: XJYYLLWYH@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patient meets the diagnostic criteria of National Institutes of Health (NIH)Ⅲ type prostatitis;
- NIH-CPSI score > 10;
- The symptoms lasted for more than 3 months and failed to respond to drug treatment for more than 1 month;
- Age ≥18 years old and ≤60 years old agrees and signs the informed consent;
- Those who did not receive other similar treatment regimens during treatment.
Exclusion Criteria:
- All kinds of bacterial infection caused by acute or chronic orchitis or epididymitis, acute or chronic prostatitis, lower urinary tract infection;
- Benign prostatic hyperplasia, prostate cancer, neurogenic bladder, urethral malformation or stricture and severe neurosis;
- For patients with local pain as the main manifestation, attention should be paid to the exclusion of other lesions in the lower abdomen, perineum, lsosacral sites, such as ureteral calculi, bladder calculi, inguinal hernia, pubis, varicocele, epididymitis, rectocolic diseases, lsodorsal myofascitis, etc.;
- Complicated with heart, brain, liver and hematopoietic system and other serious primary diseases, local skin infection or skin lesions in the treatment site;
- People who have metal implants in their bodies cannot cooperate, such as patients with mental illness.
- People who are allergic to the treatment of electrical stimulation or allergic to a variety of drugs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Electrophysiological treatment group
Two electrodes covered the two acupoints of Zhongliao and Huiyang, one electrode covered the three acupoints of Zhongji, Guanyuan and Qihai, and two skin paste electrodes covered the three acupoints of Sanyinjiao, and connected the electric stimulation therapy instrument for 30 minutes.
The intensity was based on the patient's tolerance.
4 weeks before the course of treatment, the treatment was performed once a day, 3 times a week.In the last 4 weeks, 20 times were performed twice a week.Fluoroquinolones and alpha blockers were administered according to the patient's symptoms.
|
Using the percutaneous electrical nerve stimulation instrument to different points of the body
|
NO_INTERVENTION: Regular treatment group
Fluoroquinolones and alpha blockers were administered according to the patient's symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI)
Time Frame: through study completion, an average of 1 year
|
Improvement rate = [(score before treatment - score at the end of treatment)/score before treatment] ×100% The improvement rate ≥75% was considered to be significant.The improvement rate < 75% and ≥50% were considered to be better. The improvement rate < 50% and ≥25% were considered as average efficacy.The improvement rate < 25% indicates poor efficacy. |
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
international prostate symptom score (IPSS)
Time Frame: through study completion, an average of 1 year
|
The score improved significantly from baseline
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 13, 2021
Primary Completion (ANTICIPATED)
May 1, 2023
Study Completion (ANTICIPATED)
June 30, 2023
Study Registration Dates
First Submitted
June 23, 2021
First Submitted That Met QC Criteria
July 14, 2021
First Posted (ACTUAL)
July 26, 2021
Study Record Updates
Last Update Posted (ACTUAL)
July 26, 2021
Last Update Submitted That Met QC Criteria
July 14, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2002020080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
To carry out real world research on the application of electrophysiology and other suitable technologies in the prevention and treatment of male diseases in medical institutions at all levels in Northwest China, and establish a database for the prevention and treatment of male diseases in Northwest China, so as to provide a basis for the formulation of guidelines or consensus on the application of electrophysiology for the prevention and treatment of male diseases in China.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Prostatitis
-
Ain Shams UniversityCompletedDutasteride | Category IIIB Chronic ProstatitisEgypt
-
National Institute of Diabetes and Digestive and...CompletedChronic Prostatitis With Chronic Pelvic Pain Syndrome
-
Aziende Chimiche Riunite Angelini Francesco S.p.AHippocrates ResearchCompleted
-
University of Roma La SapienzaCompleted
-
Adrian GasparCompletedChronic Prostatitis With Chronic Pelvic Pain Syndrome | ProstatodyniaArgentina
-
Cairo UniversityUnknownChronic Non Bacterial Prostatitis
-
The Krongrad InstituteUnknownProstatitis | Chronic Prostatitis With Chronic Pelvic Pain SyndromeUnited States
-
Second Affiliated Hospital, School of Medicine,...Peking University First Hospital; Changhai Hospital; First Affiliated Hospital... and other collaboratorsUnknown
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedCystitis, Interstitial | Painful Bladder Syndrome | Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Bacterial Prostatitis | Asymptomatic Inflammatory ProstatitisUnited States
-
Shanghai University of Traditional Chinese MedicineHuashan HospitalActive, not recruitingChronic Prostatitis With Chronic Pelvic Pain SyndromeChina
Clinical Trials on Percutaneous electrical nerve stimulation treatment
-
César Fernández-de-las-PeñasCompleted
-
Children's Hospital of Orange CountyInnovative Health SolutionsRecruitingCOVID-19 | Post-Concussion Syndrome | COVID Long-HaulUnited States
-
Medical College of WisconsinUniversity College, London; Indiana UniversityRecruitingFunctional Gastrointestinal Disorders | Postural Orthostatic Tachycardia Syndrome | Hypermobile Ehlers-Danlos Syndrome | Autonomic Nervous System Disease | Autonomic Nervous System ImbalanceUnited States
-
InventramKoç UniversityCompletedParkinson DiseaseTurkey
-
Universidad Rey Juan CarlosRecruitingNeuropathic Pain | Peripheral Neuropathy | Percutaneous Electrical Nerve StimulationSpain
-
Medical College of WisconsinChildren's Wisconsin; Advancing a Healthier Wisconsin Endowment (AHW)RecruitingParoxysmal Sympathetic HyperactivityUnited States
-
Universidad Rey Juan CarlosCompleted
-
Riphah International UniversityRecruitingCerebral Palsy | ConstipationPakistan
-
Karolinska University HospitalActive, not recruitingHip Fractures | Hip Osteoarthritis | Orthopedic Disorder | Post Operative PainSweden
-
University of L'AquilaCompleted